NEW YORK (GenomeWeb) – Zeesan Biotech has released a high-risk human papillomavirus genotyping test as a CE-IVD product, the company announced today.

The Xiamen, China-based firm's MeltPro High Risk HPV Genotyping Assay tests for 14 types of HPV, with a cellular gene used as an internal positive control. It runs on the firm's MeltPro System, and processes cervical cell specimens collected in Becton Dickinson's SurePath preservative or derived from the Hologic Thinprep Pap test.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.